Neogen Corporation
NEOGNASDAQHealthcare● Active
$8.90
+$0.00(+0.14%)
Market Cap$1.9B
P/E Ratio—
52W High$11.43
52W Low$4.56
Neogen Corporation (NEOG) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
NEOG · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 9, 2026EPS Actual
$0.09
Est. $0.04 · +125.0%
Revenue
$0.21B
Est. $0.20B · +3.3%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 9, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 3-Quarter EPS Beat Streak
NEOG reports quarterly as a NASDAQ-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | $0.05 | — | — | — | $0.21B | — |
| ▲ Q2 FY2026 | Apr 9, 2026 | $0.04 | $0.09 | +125.0% | $0.21B | $0.20B | +3.3% |
| ▲ Q1 FY2026 | Jan 8, 2026 | $0.07 | $0.10 | +42.9% | $0.22B | $0.21B | +8.2% |
| ▲ Q4 FY2025 | Oct 9, 2025 | -$0.07 | $0.04 | +154.1% | $0.21B | $0.20B | +3.0% |
| ▼ Q3 FY2025 | Jul 29, 2025 | $0.08 | $0.05 | -37.5% | $0.23B | $0.20B | +11.3% |
| ▼ Q2 FY2025 | Apr 9, 2025 | $0.13 | $0.10 | -23.1% | $0.22B | $0.22B | -0.7% |
| ▲ Q1 FY2025 | Jan 10, 2025 | $0.09 | $0.11 | +22.2% | $0.23B | $0.23B | +1.4% |
| ▼ Q4 FY2024 | Oct 10, 2024 | $0.09 | $0.07 | -17.6% | $0.22B | $0.22B | +0.9% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
$0.05
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 9, 2026Beat
EPS Actual
$0.09
EPS Est.
$0.04
EPS Surpr.
+125.0%
Revenue
$0.21B
Q1 FY2026
Jan 8, 2026Beat
EPS Actual
$0.10
EPS Est.
$0.07
EPS Surpr.
+42.9%
Revenue
$0.22B
Q4 FY2025
Oct 9, 2025Beat
EPS Actual
$0.04
EPS Est.
-$0.07
EPS Surpr.
+154.1%
Revenue
$0.21B
Q3 FY2025
Jul 29, 2025Miss
EPS Actual
$0.05
EPS Est.
$0.08
EPS Surpr.
-37.5%
Revenue
$0.23B
Q2 FY2025
Apr 9, 2025Miss
EPS Actual
$0.10
EPS Est.
$0.13
EPS Surpr.
-23.1%
Revenue
$0.22B
Q1 FY2025
Jan 10, 2025Beat
EPS Actual
$0.11
EPS Est.
$0.09
EPS Surpr.
+22.2%
Revenue
$0.23B
Q4 FY2024
Oct 10, 2024Miss
EPS Actual
$0.07
EPS Est.
$0.09
EPS Surpr.
-17.6%
Revenue
$0.22B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2028 | $-0.03 | $-0.03 | $-0.03 | 1 |
| Q1 FY2028 | $-0.02 | $-0.02 | $-0.02 | 1 |
| Q4 FY2027 | $-0.03 | $-0.03 | $-0.03 | 1 |
| Q3 FY2027 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Q2 FY2027 | $0.08 | $0.09 | $0.09 | 1 |
| Q1 FY2027 | $0.06 | $0.07 | $0.07 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2028 | $0.2B | $0.2B | $0.2B | 1 |
| Q1 FY2028 | $0.2B | $0.2B | $0.2B | 1 |
| Q4 FY2027 | $0.2B | $0.2B | $0.2B | 2 |
| Q3 FY2027 | $0.2B | $0.2B | $0.2B | 2 |
| Q2 FY2027 | $0.2B | $0.2B | $0.2B | 2 |
| Q1 FY2027 | $0.2B | $0.2B | $0.2B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 9, 2026 | +125.0% | $10.34 | $10.04 | -2.90% |
| ▲ Q1 FY2026 | Jan 8, 2026 | +42.9% | $7.38 | $9.71 | +31.57% |
| ▲ Q4 FY2025 | Oct 9, 2025 | +154.1% | $5.82 | $6.78 | +16.49% |
| ▼ Q3 FY2025 | Jul 29, 2025 | -37.5% | $5.42 | $4.83 | -10.89% |
| ▼ Q2 FY2025 | Apr 9, 2025 | -23.1% | $7.04 | $5.02 | -28.69% |
| ▲ Q1 FY2025 | Jan 10, 2025 | +22.2% | $13.07 | $12.36 | -5.43% |
| ▼ Q4 FY2024 | Oct 10, 2024 | -17.6% | $14.85 | $13.79 | -7.14% |
| ▼ Q3 FY2024 | Jul 30, 2024 | -16.7% | $17.30 | $17.58 | +1.62% |
Q2 FY2026-2.90%
Report Date
Apr 9, 2026
EPS Beat/Miss
+125.0%
Price Before
$10.34
Price After
$10.04
Q1 FY2026+31.57%
Report Date
Jan 8, 2026
EPS Beat/Miss
+42.9%
Price Before
$7.38
Price After
$9.71
Q4 FY2025+16.49%
Report Date
Oct 9, 2025
EPS Beat/Miss
+154.1%
Price Before
$5.82
Price After
$6.78
Q3 FY2025-10.89%
Report Date
Jul 29, 2025
EPS Beat/Miss
-37.5%
Price Before
$5.42
Price After
$4.83
Q2 FY2025-28.69%
Report Date
Apr 9, 2025
EPS Beat/Miss
-23.1%
Price Before
$7.04
Price After
$5.02
Q1 FY2025-5.43%
Report Date
Jan 10, 2025
EPS Beat/Miss
+22.2%
Price Before
$13.07
Price After
$12.36
Q4 FY2024-7.14%
Report Date
Oct 10, 2024
EPS Beat/Miss
-17.6%
Price Before
$14.85
Price After
$13.79
Q3 FY2024+1.62%
Report Date
Jul 30, 2024
EPS Beat/Miss
-16.7%
Price Before
$17.30
Price After
$17.58
Avg Beat Reaction+9.93%
Avg Miss Reaction-11.28%
Beat Rate4 / 8 quarters
Largest Move+31.57% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: NEOG ends December
Neogen Corporation (NEOG) most recently reported earnings on April 9, 2026 for Q2 FY2026, posting EPS of $0.09 — beating the analyst consensus of $0.04 by +125.0%. NEOG has beaten EPS estimates for 3 consecutive quarters. The next NEOG earnings date is expected around September 1, 2026.
Each quarter, investors track NEOG earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NEOG revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
NEOG's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
NEOG earnings · 5 questionsNeogen Corporation's next earnings report is expected around September 1, 2026. NEOG typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; NEOG historically reports after market close (AMC).
NEOG earnings datewhen is NEOG earningsNEOG next earnings datewhen does NEOG report earningsNEOG earnings calendar
▸ Source: FMP · Neogen Corporation SEC filings · US GAAP · Neogen Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026